1.
2.
Associations of Advanced Glycation End-Products With Cognitive Functions in Individuals With and Without Type 2 Diabetes: The Maastricht Study
by Spauwen, P. J. J
The journal of clinical endocrinology and metabolism, 2015, Vol.100 (3), p.951-960
3.
The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities
by Schram, M.T
European journal of epidemiology, 2014, Vol.29 (6), p.439-451
4.
Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes - The Hoorn study
by Schram, M.T
Hypertension (Dallas, Tex. 1979), 2004, Vol.43 (2), p.176-181
5.
Carotid stiffness is associated with retinal microvascular dysfunction: the Maastricht study
by Zhou, T
Diabetologia, 2019, Vol.62 (Supp. 1), p.S501-S501
6.
Higher levels of daily physical activity are associated with better skin microvascular function in type 2 diabetes: The Maastricht Study
by van der Heide, F.C.T
Diabetologia, 2019, Vol.62 (Suppl 1), p.S546-S546
7.
8.
Association Between Arterial Stiffness and Skin Microvascular Function: The SUVIMAX2 Study and The Maastricht Study
by van Sloten, T.T
American journal of hypertension, 2015, Vol.28 (7), p.868-876
9.
Glucose metabolism status is associated with impaired microvascular function: the Maastricht study
by Sorensen, B.M
Diabetologia, 2016, Vol.59, p.S101-S102
10.
Endothelial Dysfunction Plays a Key Role in Increasing Cardiovascular Risk in Type 2 Diabetes The Hoorn Study
by van Sloten, T.T
Hypertension (Dallas, Tex. 1979), 2014, Vol.64 (6), p.1299-1305
11.
12.
Re: Adiponectin and renal function: pitfalls of renal function estimates and corrections for BSA
by Schalkwijk, C.G
The journal of clinical endocrinology and metabolism, 2006
13.
Setting and registry characteristics affect the prevalence and nature of multimorbidity in the elderly
by Schram, M.T
Journal of clinical epidemiology, 2008, Vol.61 (11), p.1104-1112
14.
Setting and registry characteristics affect the prevalence and nature of multimorbidity in the elderly
by Schram, M.T
Journal of clinical epidemiology, 2008, Vol.61 (11), p.1104-1112
15.
Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study
by Schram, M.T
Hypertension (Dallas, Tex. 1979), 2005, Vol.46 (1), p.232-237
16.
Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study
by van Meeteren-Schram, M.T
Hypertension (Dallas, Tex. 1979), 2005, Vol.46 (1), p.232-237
